TRANSLATING ADVANCES IN MOLECULAR ONCOLOGY INTO IMPROVED CARE FOR PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

Grant number: 1079560 | Funding period: 2015 - 2019

Completed

Abstract

The purpose of my research is to develop and integrate into routine practice better treatment paradigms for patients with blood cancers – leukaemias, lymphomas, myeloma. My research seeks to (i) bring a new class of anti-cancer targeted therapy, inhibitors of Bcl-2, into routine care; (ii) discover the genetic changes that explain why slow growing lymphoid cancers change into rapidly fatal lymphomas; and (iii) integrate new molecular tests into the management of patients with acute leukaemia.

Researchers